Φορτώνει......
Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
BACKGROUND: A subset of critically ill COVID-19 patients develop a hyperinflammatory state. Anakinra, a recombinant interleukin-1 receptor antagonist, is known to be effective in several hyperinflammatory diseases. We investigated the effects of anakinra on inflammatory parameters and clinical outco...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Crit Care |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7726611/ https://ncbi.nlm.nih.gov/pubmed/33302991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03364-w |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|